Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-002048

Director bought 200,000 shares at $21.00 ($4,200,000)

  • Director acquired 5,826,832 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Jovan-Embiricos Morana · Director

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-12 Conversion : show line 1 in the form +1,136,525 1,136,525 I
2021-01-12 Conversion : show line 2 in the form +2,912,345 2,912,345 I
2021-01-12 Conversion : show line 3 in the form +639,295 639,295 I
2021-01-12 Conversion : show line 4 in the form +455,338 455,338 I
2021-01-12 Conversion : show line 5 in the form +182,135 182,135 I
2021-01-12 Conversion : show line 6 in the form +71,599 526,937 I
2021-01-12 Conversion : show line 7 in the form +143,198 325,333 I
2021-01-12 Conversion : show line 8 in the form +71,599 71,599 I
Open-market purchases · 200,000 sh · avg $21.00 · $4,200,000

Table II: Derivative

9 lines
Date Transaction Shares Owned after D/I
2021-01-12 Conversion : show line 12 in the form Series Seed Convertible Preferred Stock −8,000,000 0 I
2021-01-12 Conversion : show line 13 in the form Series A Convertible Preferred Stock −20,500,000 0 I
2021-01-12 Conversion : show line 14 in the form Series A Convertible Preferred Stock −4,500,000 0 I
2021-01-12 Conversion : show line 15 in the form Series B Convertible Preferred Stock −3,205,128 0 I
2021-01-12 Conversion : show line 16 in the form Series B Convertible Preferred Stock −1,282,051 0 I
2021-01-12 Conversion : show line 17 in the form Series C Convertible Preferred Stock −503,988 0 I
2021-01-12 Conversion : show line 18 in the form Series C Convertible Preferred Stock −1,007,977 0 I
2021-01-12 Conversion : show line 19 in the form Series C Convertible Preferred Stock −503,988 0 I
2021-01-12 Conversion : show line 20 in the form Series C Convertible Preferred Stock −1,511,966 0 I
Loading xslF345X03/doc4.xml…